Park J W, Chun Y S, Kim Y H, Kim C H, Kim M S
Department of Pharmacology, Seoul National University, College of Medicine, Chongno-gu, Korea.
Life Sci. 1997;60(24):2207-19. doi: 10.1016/s0024-3205(97)00236-1.
The present study was performed to test whether the ischemic preconditioning could reduce mitochondrial O2.- production and prevent mitochondrial respiratory impairment upon reperfusion of ischemic hearts. The isolated perfused rat hearts were subjected to 30 min of global ischemia and 20 min of reperfusion. Ischemic preconditioning was performed, involving three 5-min periods of ischemia, each followed by a 5-min reperfusion just before a sustained ischemia. Ischemic preconditioning improved the post-ischemic cardiac function and reduced LDH release and malondialdehyde production upon reperfusion. 02.- generation of mitochondria isolated from the preconditioned hearts was significantly lower than that of mitochondria from the non-preconditioned hearts, and none of the activities of mitochondrial antioxidant enzymes (SOD, catalase, glutathione peroxidase) was altered as a consequence of the ischemic preconditioning alone. The impairment of mitochondrial state 3 respiration induced by ischemia and reperfusion was prevented by ischemic preconditioning. Amytal, a reversible respiratory chain blocker suppressing 02.- production in mitochondria, prevented the ischemia/reperfusion injury. The cardioprotective effect of Amytal could not be distinguished from that of ischemic preconditioning. These results suggest that the cardioprotective effect of ischemic preconditioning against the ischemia/reperfusion injury is attributed partly to the reduction of mitochondrial oxygen radical generation and prevention of the respiratory impairment during ischemia and reperfusion.
本研究旨在测试缺血预处理是否能减少线粒体超氧阴离子的产生,并预防缺血心脏再灌注时的线粒体呼吸功能障碍。将离体灌注的大鼠心脏进行30分钟的全心缺血和20分钟的再灌注。进行缺血预处理,包括三个5分钟的缺血期,每个缺血期后紧接着在持续缺血前进行5分钟的再灌注。缺血预处理改善了缺血后心脏功能,减少了再灌注时乳酸脱氢酶的释放和丙二醛的产生。从预处理心脏分离的线粒体的超氧阴离子生成明显低于未预处理心脏的线粒体,并且仅缺血预处理不会改变线粒体抗氧化酶(超氧化物歧化酶、过氧化氢酶、谷胱甘肽过氧化物酶)的活性。缺血预处理可预防缺血和再灌注诱导的线粒体状态3呼吸功能障碍。阿米妥,一种可逆的呼吸链阻断剂,可抑制线粒体中超氧阴离子的产生,可预防缺血/再灌注损伤。阿米妥的心脏保护作用与缺血预处理的作用无法区分。这些结果表明,缺血预处理对缺血/再灌注损伤的心脏保护作用部分归因于线粒体氧自由基生成的减少以及对缺血和再灌注期间呼吸功能障碍的预防。